Australia markets closed

MGC Pharmaceuticals Limited (MXC.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0110+0.0010 (+10.00%)
At close: 03:45PM AEDT
Currency in AUD

Valuation measures4

Market cap (intra-day) 31.52M
Enterprise value 33.99M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.97
Price/book (mrq)5.40
Enterprise value/revenue 7.18
Enterprise value/EBITDA -1.67

Trading information

Stock price history

Beta (5Y monthly) 1.28
52-week change 3-68.75%
S&P500 52-week change 3-8.47%
52-week high 30.0320
52-week low 30.0090
50-day moving average 30.0116
200-day moving average 30.0161

Share statistics

Avg vol (3-month) 31.46M
Avg vol (10-day) 32.2M
Shares outstanding 52.87B
Implied shares outstanding 6N/A
Float 82.48B
% held by insiders 19.17%
% held by institutions 16.12%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 321 Aug 2012

Financial highlights

Fiscal year

Fiscal year ends 30 June 2022
Most-recent quarter (mrq)30 June 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-327.54%

Management effectiveness

Return on assets (ttm)-45.27%
Return on equity (ttm)-218.54%

Income statement

Revenue (ttm)4.73M
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)-3.90%
Gross profit (ttm)562.87k
EBITDA -15.4M
Net income avi to common (ttm)-20.35M
Diluted EPS (ttm)-0.0080
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.89M
Total cash per share (mrq)0
Total debt (mrq)4.35M
Total debt/equity (mrq)84.03
Current ratio (mrq)0.84
Book value per share (mrq)0.00

Cash flow statement

Operating cash flow (ttm)-12.16M
Levered free cash flow (ttm)-8.81M